CELONIC to become a long-term partner of the Federal Republic of Germany for vaccine supply
Heidelberg, Germany, March 24th 2022 – The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and...
BioRN Team
Strategy & Mission
Strategy & Mission
BioRN Annual Conference 2018
BioRN Annual Conference 2018
HAE Visionary Seminar
Directory
News
Search
- Jan 13
- 3 min
Apogenix Receives €20.7 Million in Public Funding
Apogenix Receives €20.7 Million in Public Funding for Pivotal Study and Preparation for Market Production of Asunercept for the Treatment...
- Dec 12, 2021
- 3 min
Visualising Cell Structures in Three Dimensions in Mere Minutes
Heidelberg researchers are working on a rapid process for 3D imaging of cells Viral pathogens like the SARS-CoV-2 coronavirus change the...
- Oct 19, 2021
- 4 min
Genomic tracking of the COVID-19 pandemic in England
The COVID-19 crisis that gripped England between September 2020 and June 2021 can be thought of as a series of overlapping epidemics,...
- Sep 10, 2021
- 1 min
Funding for Covid-19 drug development announced to two BioRN members
The Federal Ministry of Health (BMG) and the Federal Ministry of Education and Research (BMBF) are continuing to drive forward the joint...
- Sep 1, 2021
- 3 min
Innovative Drug Discovery
Heidelberg research group seeks and develops inhibitors against flavi- and coronaviruses New drugs are intended to help stop viral...
- Aug 29, 2021
- 2 min
Superspreading events as drivers of SARS-CoV-2 evolution
What evolution has SARS-CoV-2 undergone since the beginning of the pandemic? Scientists from the German Cancer Research Center, in...
- Aug 24, 2021
- 2 min
MASSIF-1 beamline in Grenoble supports COVID-19 drug discovery
MASSIF-1, run jointly by EMBL Grenoble and the ESRF, is a beamline for macromolecular crystallography. It is used by the research...
- Jun 17, 2021
- 1 min
AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its...
- Apr 26, 2021
- 2 min
First hospitalized COVID-19 patient treated with the antibody drug candidate COR-101
• CORAT Therapeutics initiated a Phase Ib/II clinical trial evaluating the safety, tolerability, and efficacy of COR-101 in a total of 45...
- Apr 23, 2021
- 3 min
Different immune responses identified in patients with COVID-19
The largest study of its type in the UK has identified differences in the immune response to COVID-19 in people with no symptoms,...
- Apr 14, 2021
- 2 min
Putting computing power together against SARS-CoV-2
The first vaccines authorised for use are raising hopes for an end to the pandemic. What is still missing, however, is an effective ...
- Mar 30, 2021
- 2 min
Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses
Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year More...
- Mar 16, 2021
- 3 min
CORAT Therapeutics GmbH obtained regulatory authorization for clinical phase Ib/II trial
• CORAT Therapeutics antibody therapy obtained approval to start its clinical trial. • COR-101 is a human antibody that blocks virus...
- Feb 22, 2021
- 1 min
Multiplex antibody tests
Essential helpers to fight the coronavirus The antibody test developed in Reutlingen is sensitive and accurate. This is also confirmed...
- Dec 18, 2020
- 2 min
Human antibody against COVID-19 ready for clinical trials
Braunschweig , Nov 18, 2020. CORAT Therapeutics CEO Dr. Andreas Herrmann today announced the completion of the production campaign ofthe...
- Dec 7, 2020
- 3 min
How human antibody COR-101 neutralizes the coronavirus SARS-CoV-2
Dec. 4, 2020, Braunschweig, Germany – Because SARS-CoV-2 is a novel virus, many people have not yet developed antibodies against the...
- Nov 19, 2020
- 2 min
Human antibody against COVID-19 ready for clinical trials
YUMAB spin-off CORAT Therapeutics announced that the first major batch of its SARS-CoV-2 blocking antibody COR-101 has been produced and...
- Oct 9, 2020
- 2 min
Innovation Award of the State of Lower Saxony for CORAT Consortium
Innovation Award of the State of Lower Saxony for CORAT Consortium for the collaborative fast track development of COVID-19 antibodies....
- Sep 22, 2020
- 2 min
Transporting temperature-sensitive COVID-19 vaccines
We all hope that a COVID-19 vaccine is on the horizon - but the global cold chain must be prepared to distribute these vaccines around ...